InspireMD (NYSE:NSPR) and Longview Acquisition Corp. II (NYSE:LGV) Head to Head Contrast
InspireMD (NYSE:NSPR) and Longview Acquisition Corp. II (NYSE:LGV) Head to Head Contrast
InspireMD (NYSE:NSPR – Get Rating) and Longview Acquisition Corp. II (NYSE:LGV – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
INSPREMD（紐約證券交易所代碼：NSPR-獲得評級）和長景收購公司 II（紐約證券交易所代碼：LGV-獲得評級）都是小型公司，但哪家投資更好？我們將根據兩家企業的收益，盈利能力，風險，分析師建議，股息，估值和機構所有權的實力進行比較。
Analyst Ratings
分析師評級
This is a breakdown of current ratings and target prices for InspireMD and Longview Acquisition Corp. II, as provided by MarketBeat.
這是由 MarketBeat 提供的 InspireMD 和長景收購股份有限公司 II 的當前評級和目標價格的細分。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InspireMD | 0 | 0 | 0 | 0 | N/A |
| Longview Acquisition Corp. II | 0 | 0 | 0 | 0 | N/A |
| 銷售評級 | 保留評分 | 購買評級 | 強大的買入評級 | 評級分數 | |
| 億派心靈醫學 | 0 | 0 | 0 | 0 | N/A |
| 朗威收購股份有限公司 | 0 | 0 | 0 | 0 | N/A |
Profitability
盈利
This table compares InspireMD and Longview Acquisition Corp. II's net margins, return on equity and return on assets.
此表格比較 InspireMD 和長景收購股份有限公司 II 的淨利潤率、權益回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| InspireMD | -321.14% | -64.03% | -52.30% |
| Longview Acquisition Corp. II | N/A | -65.52% | 3.65% |
| 淨利潤 | 權益回報率 | 資產回報率 | |
| 億派心靈醫學 | -321.14% | -64.03% | -52.30% |
| 朗威收購股份有限公司 | N/A | -65.52% | 3.65% |
Institutional & Insider Ownership
機構和內幕所有權
1.3% of InspireMD shares are owned by institutional investors. Comparatively, 66.3% of Longview Acquisition Corp. II shares are owned by institutional investors. 3.8% of InspireMD shares are owned by insiders. Comparatively, 26.4% of Longview Acquisition Corp. II shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
1.3% 的股份由機構投資者擁有。相比之下，長景收購股份有限公司 II 股份的 66.3% 由機構投資者擁有。3.8% 的億派股份由內部人士擁有。相比之下，長景收購股份有限公司 II 股份的 26.4% 由內部人士擁有。強大的機構擁有權表明，大型資金經理，捐贈基金和對沖基金認為股票有望實現長期增長。
Risk and Volatility
風險及波動性
InspireMD has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Longview Acquisition Corp. II has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.
InspireMD 的測試版為 1.13，這意味著其股票價格比標普 500 的波動性高 13％。相比之下，長景收購公司 II 的測試版為 0.04，這意味著其股票價格比標普 500 少 96％ 的波動性。
Valuation & Earnings
估值及收益
This table compares InspireMD and Longview Acquisition Corp. II's revenue, earnings per share (EPS) and valuation.
此表格比較 InspireMD 和長景收購股份有限公司 II 的收入、每股盈利 (EPS) 和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InspireMD | $4.49 million | 2.41 | -$14.92 million | ($2.27) | -0.57 |
| Longview Acquisition Corp. II | N/A | N/A | $7.40 million | N/A | N/A |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股盈利 | 市盈比率 | |
| 億派心靈醫學 | 四百四十九萬美元 | 2.41 | -一千四百九十二萬元 | (二元二十七元) | -0.57 |
| 朗威收購股份有限公司 | N/A | N/A | 七百四十萬美元 | N/A | N/A |
Longview Acquisition Corp. II has lower revenue, but higher earnings than InspireMD.
長景收購股份有限公司 II 的收入較低，但收益比 InspireMD 更高。
Summary
摘要
Longview Acquisition Corp. II beats InspireMD on 5 of the 8 factors compared between the two stocks.
長景收購股份有限公司 II 擊敗了 InspireMD 上的 8 個因素中的 8 個因素兩個股票之間的比較。
About InspireMD
關於億派醫學
(Get Rating)
(取得評分)
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
InspireMD, Inc. 是一家醫療器械公司，致力於開發和商業化其專有的 MicronNet 支架平台技術，用於治療複雜血管和冠狀動脈疾病。其產品主要用於急性冠狀動脈綜合徵患者，特別是急性心肌梗死和陰莖靜脈移植冠狀動脈介入手術。該公司成立於 2005 年，總部位於以色列特拉維夫。
About Longview Acquisition Corp. II
關於朗維收購股份有限公司 II
(Get Rating)
(取得評分)
Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.
長景收購股份有限公司 II 沒有重大業務。它打算與一個或多個企業實現合併，資本證券交易所，資產收購，股票購買，重組或類似業務合併。該公司打算專注於醫療保健、工業、消費者、媒體、科技和技術服務領域的業務。該公司成立於 2020 年，總部位於紐約州紐約。
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
接收新聞和評分每日 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 InspireMD 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。